Aldeyra Therapeutics ALDX
NASDAQ ALDX
$1.17 -0.12 (-9.30%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aldeyra Therapeutics (ALDX) Return on Assets [ROA] (2014 - 2026)

Updated

Aldeyra Therapeutics (ALDX) posted Return on Assets [ROA] of -40.44% for Q2 2026, up 16.39 percentage points from -56.82% a year earlier but down 0.92 percentage points from the prior quarter.

Analysis

Aldeyra Therapeutics (ALDX) Return on Assets [ROA] (2014 - 2026) Analysis & Trends

For FY2025, Aldeyra Therapeutics' Return on Assets [ROA] came in at -38.32%, up 5.85 percentage points from FY2024.

  • Annual Return on Assets [ROA] shows a five-year change of +8.96 percentage points (FY2020 to FY2025).
  • In prior years, Aldeyra Therapeutics' Return on Assets [ROA] was -44.16% in FY2024 (-21.38 pp), -22.78% in FY2023 (+7.15 pp), -29.93% in FY2022 (+6.58 pp) and -36.51% in FY2021 (+10.77 pp).
  • Quarterly Return on Assets [ROA] has run from a low of -58.34% in Q1 2025 to a high of -20.72% in Q1 2024 over five years.
  • On a year-over-year basis, Return on Assets [ROA] has increased in each of the last three quarters, with an average year-over-year change of -9.20 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q3 2021, with a gain of 28.12 percentage points; the weakest was Q1 2025, with a drop of 37.62 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -39.51% (Q1 2026), -45.17% (Q4 2025) and -53.08% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 10.47%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 4.65%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 28.37%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.10%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 9.29%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -6.13%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 2.14%
10 Aldeyra Therapeutics 77.81 Mn 77.81 Mn - -40.44%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -40.44%
Mar 31, 2026 -39.51%
Dec 31, 2025 -45.17%
Sep 30, 2025 -53.08%
Jun 30, 2025 -56.82%
Mar 31, 2025 -58.34%
Dec 31, 2024 -50.33%
Sep 30, 2024 -36.81%
Jun 30, 2024 -28.33%
Mar 31, 2024 -20.72%
Dec 31, 2023 -25.40%
Sep 30, 2023 -30.17%
Jun 30, 2023 -32.15%
Mar 31, 2023 -34.82%
Dec 31, 2022 -33.44%
Sep 30, 2022 -33.21%
Jun 30, 2022 -31.21%
Mar 31, 2022 -27.76%
Dec 31, 2021 -24.06%
Sep 30, 2021 -21.17%
API Access

Aldeyra Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ALDX&period=max&api_key=YOUR_API_KEY